- Home
- PRA vs IMTX Comparison
PRA vs IMTX Comparison
Compare PRA & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PRA | IMTX |
|---|---|---|
| Founded | 1976 | N/A |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PRA | IMTX |
|---|---|---|
| Price | $23.89 | $12.28 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $22.50 | $19.25 |
| AVG Volume (30 Days) | 380.2K | ★ 561.1K |
| Earning Date | 11-04-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.66 | N/A |
| Revenue | ★ $1,120,385,000.00 | $99,445,031.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.24 | $13.52 |
| P/E Ratio | $36.29 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.90 | $3.30 |
| 52 Week High | $24.22 | $12.38 |
Technical Indicators
Market Signals| Indicator | PRA | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 39.70 | 64.98 |
| Support Level | $23.88 | $9.76 |
| Resistance Level | $24.12 | $11.00 |
| Average True Range (ATR) | 0.09 | 0.86 |
| MACD | -0.02 | 0.08 |
| Stochastic Oscillator | 4.08 | 94.19 |
Price Performance
Historical ComparisonAbout PRA ProAssurance Corporation
ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in five segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, Lloyd's Syndicate, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&C activities, followed by Worker's Compensation.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.